Stock VTR VENTAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Ventas, Inc.

Equities

VTR

US92276F1003

Market Closed - Nyse
Other stock markets
 04:00:03 2024-04-23 pm EDT 		5-day change 1st Jan Change
43.54 USD +0.95% Intraday chart for Ventas, Inc. +4.46% -12.64%
Mar. 18 Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50 MT
Mar. 12 Ventas, Inc. Declares First Quarter 2024 Dividend, Payable on April 18, 2024 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation
  • The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

  • The company has insufficient levels of profitability.
  • One of the major weak points of the company is its financial situation.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

1st Jan change Capi. Investor Rating ESG Refinitiv
VENTAS, INC. Stock Ventas, Inc.
-12.64% 17.37B
A-
WELLTOWER INC. Stock Welltower Inc.
+3.07% 54.15B
A-
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-6.84% 12.94B
A
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+0.10% 7.42B
B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-18.98% 5.43B
B-
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+6.93% 3.18B
C-
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
-3.50% 3.16B
C+
AEDIFICA SA Stock Aedifica SA
-4.79% 3.05B
B+
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
-5.40% 2.74B
C
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+12.34% 2.71B
C-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. VTR Stock
  4. Ratings Ventas, Inc.